Comparative Effectiveness Of Low Extra-Corporeal Shock Wave Versus Acetylcholine Iontophoresis On Type2 Diabetic Neuropathy

Launched by SOUTH VALLEY UNIVERSITY · Jun 25, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at two different treatments to help improve blood flow and reduce symptoms in people with type 2 diabetes who also have nerve damage, known as diabetic neuropathy. The study will compare low-intensity shock wave therapy, which uses gentle sound waves, to a method called acetylcholine iontophoresis, which uses a small electrical current to deliver a medication through the skin. The goal is to see which treatment works better for improving circulation and easing discomfort.

To participate in this study, you need to be an adult with type 2 diabetes and stable symptoms of nerve damage. It's important that your diabetes is being managed with medications that won’t change during the trial. However, some people won't be eligible, such as those with certain heart conditions, skin allergies, or other specific health issues. The trial is currently not recruiting participants, so it’s a good time to learn more and see if you might want to join once it starts. If you do participate, you can expect to receive one of the two treatments and be monitored for your progress.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients have to be symptomatically stable with type 2 diabetes mellitus complicated with peripheral neuropathy.
• • Optimized pharmacological treatment that will be remained unchanged throughout the study.
• Exclusion Criteria:
• • Implanted cardiac pacemakers.
• • Patients with known skin allergies.
• • Presence of skin inflammations.
• • Peripheral vascular disease.
• • Patients with unstable angina pectoris.
• • Progressive ventricular dysrhythmia.
• • Intermittent claudication.